Aiforia - Medical Image Analysis Software

Any financing solution that is good for the shareholders requires favorable sales development for Aiforia. If that doesn’t happen, the share will eventually go to zero. In that sense, I don’t understand how this is seen as a negative point regarding the financing… if we were to continue with share issues, in an unfavorable sales development scenario, we would soon be at a subscription price of something like 10 cents and a hundred million new shares.

1 Like